National Institute Of Dental And Craniofacial Research (nidcr)

This study tested whether a drug called burosumab could safely raise low phosphate levels in people with fibrous dysplasia, a condition that weakens bones. Twelve participants aged 1 and older received injections of the drug at home once or twice a month for 48 weeks. Researchers…

This study tested whether a medication called denosumab could slow or stop the progression of fibrous dysplasia, a rare bone disease, in children. Fifteen children aged 4 to 14 received denosumab injections every four weeks for nearly a year. Researchers measured changes in bone …

This study tested a new drug called encaleret in 13 adults with low calcium levels after neck surgery damaged their parathyroid glands. Researchers wanted to see if the drug could help normalize blood calcium levels while also keeping urine calcium in a safe range to protect the …

This study aimed to understand how COVID-19 spreads, especially by people who don't feel sick. Researchers collected saliva, nasal swabs, and other samples from 55 people who either had COVID-19 with no or mild symptoms, or who had been in close contact with someone who tested po…